Discontinuation of Infliximab & Risk of Relapse in Patients W/Complete Remission of Crohn’s Disease
Amar S. Naik, MD interview on Discontinuation of Infliximab & Risk of Relapse in Patients W/Complete Remission of Crohn’s Disease
Video originally published on PracticeUpdate.com on 07/07/2021 www.practiceupdate.com/c/1203...
--
Follow PracticeUpdate:
Twitter: / practiceupdate
Facebook: / practiceupdate
Instagram: / practiceupdate_elsevier
LinkedIn: / practiceupdate
Register for PracticeUpdate for free at www.practiceupdate.com/welcome
Пікірлер: 1
Has there been a study of patients who experience relapse to return to infliximab and if so how long was the second round of it before they showed remission again? After the every 8 week infusion, would it be recommended to extend future infusions if needed? And what of patients taking infliximab and imuran, is it recommended they stop imuran as well?